Showing results (121-130 of 129) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Gut|May 1, 1997
Intestinal tolerability of nitroxybutyl-flurbiprofen in ratsS Somasundaram, S Rafi, M Jacob, et al.The Annals of Thoracic Surgery|May 1, 1993
Cardiopulmonary bypass impairs small intestinal transport and increases gut permeabilityS K Ohri, I Bjarnason, V Pathi, et al.Gut|February 15, 2001
Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxenA A Shah, B Thjodleifsson, F E Murray, et al.Alimentary Pharmacology & Therapeutics|May 3, 2000
Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the ratS Somasundaram, G Sigthorsson, R J Simpson, et al.Alimentary Pharmacology & Therapeutics|October 15, 2013
Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patientsC Blaecher, A Smet, B Flahou, et al.AIDS (London, England)|October 1, 1996
Intestinal inflammation, ileal structure and function in HIVI Bjarnason, D R Sharpstone, N Francis, et al.Terapevticheskii Arkhiv|April 11, 2003
[Clinical and prognostic value of lesions in the gastrointestinal tract in systemic vascular purpura]N A Mukhin, S V Guliaev, O G Krivosheev, et al.Gut|November 21, 1998
Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the ratT Mahmud, S Somasundaram, G Sigthorsson, et al.The International Journal on Drug Policy|August 28, 2021
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage studyA Conway, H Valerio, A Peacock, et al.Pageof 13